Company Filing History:
Years Active: 2002-2009
Title: M Luisa Roberts: Innovator in Therapeutic Methods
Introduction
M Luisa Roberts is a notable inventor based in Noank, CT (US). He has made significant contributions to the field of therapeutic methods, particularly in the treatment of non-hematologic malignancies and the modulation of gene expression.
Latest Patents
Roberts holds 2 patents that showcase his innovative approaches. His first patent, titled "Combination treatment for non-hematologic malignancies," relates to a therapeutic method that involves administering anti-IGF-1R antibodies, specifically human anti-IGF-1R antibodies, to patients alongside at least one other therapeutic agent. This invention also includes pharmaceutical compositions that utilize these antibodies for treatment purposes. His second patent, "Antisense modulation of human Rho family gene expression," provides compositions and methods for modulating the expression of members of the human Rho gene family. This invention is particularly focused on inhibiting hyperproliferation of cells and treating conditions associated with the expression of these genes.
Career Highlights
Throughout his career, Roberts has worked with prominent companies such as Isis Pharmaceuticals, Inc. and Pfizer Corporation. His work in these organizations has contributed to advancements in therapeutic methods and drug development.
Collaborations
Roberts has collaborated with notable colleagues, including Lex M Cowsert and Antonio Gualberto. These partnerships have further enhanced his research and innovation in the field.
Conclusion
M Luisa Roberts is a distinguished inventor whose work in therapeutic methods has the potential to impact the treatment of various malignancies and hyperproliferative disorders. His contributions to the field are significant and continue to inspire future innovations.